- Jul 27, 2010
- 5,121
- 884
- 19,680
ChrisE said:So you argue that it is possible that the athlete has done everything possible to avoid contamination due to supplements, but still should be sanctioned if he is found positive from a supplement?
Sorry, I didn't make myself very clear. In responding to your post, I was referring to a threshold in an athlete's doping test. This has to be distinguished from a threshold, or a limit of detection, in a test of meat or supplements.
I'm saying that there is no value in a threshold for a dope test of an athlete below which he will automatically be cleared. But there could be such a value in a test of supplements, IMO, yes. The latter is one of the factors that would determine whether an athlete, regardless of his level, should be cleared.
Bert's case was atypical in that he had that negative test before the positive. In a more usual case, the athlete would not have a very recent negative test, and therefore one could not rule out taking of CB intentionally in large doses, with a small level resulting some time later. To be sure, an athlete could still claim it was from a supplement, and if one used a definite limit of detection for clenbuterol like 100 ng/g, one could calculate a corresponding possbile level for the athlete, if one assumed the test occurred soon after consumption of the supplement. So in this case a LOD for a supplement would translate into an effective threshold for the athlete. Of course I can see athletes trying to take advantage of this.
But I'm envisioning that the athlete would have to provide some evidence that he took supplements at that time, and in large enough amounts to cause the positive. Again, Bert has an advantage in that the panel itself ruled contaminated supplement the most likely cause; thus they did the heavy lifting for him. In a future case, the athlete wouldn't have that benefit. From Bert's case, I take it the team has a record of what supplements each rider took or might have taken, and at least could have a record of how much they took. Records like those would be crucial in fairly evaluating a tainted supplement claim. The athlete couldn't just say, I took 100 g of such-and-such that day, he would have to provide some record of it. If that is too much to ask, and maybe it is, then I think the alternative is lower the LOD for supplement testing.
Here is a copy of an email I sent to Efraim Barak, chair of the CAS panel; Mike Morgan, one of Bert's lawyers; and Michael Ashenden:
Mr. Efraim Barak
Attorney-at-law
Tel Aviv
Israel
Dear Mr. Barak:
I’m writing to you about the recent CAS hearing, which you chaired, on cyclist Alberto Contador. Like everyone else, I don’t know whether Mr. Contador intentionally took performance-enhancing substances or not. Your panel’s conclusion that he most likely took a contaminated supplement may be correct.
Nevertheless, there is a serious problem with this conclusion. His maximum reported urine level for this substance was 50 pg/ml. Using various pharmacokinetic models, we can estimate that this corresponds to an ingestion of roughly 500 ng of the substance, with 1 ug a reasonable upper bound. If a contaminated supplement was the source of this clenbuterol, the level of contamination was extremely low. So low, in fact, that it would very likely be below a widely used standard for detection of contaminants in supplements.
For example, the Dutch have set up a system, NZVT, that tests various supplements batch for batch, and issues approvals for those that meet their standards. For stimulants such as clenbuterol, this standard is 100 ng/g. The rationale for this limit of detection (LOD) is explained by de Hon and Coumans in their article “The continuing story of nutritional supplements and doping infractions” Br J Sports Med 41, 800-805 (2007):
Based on the published facts that a precursor of an anabolic steroid in an amount between 1–10 μg can cause a positive doping test,18,24 and based on the fact that athletes easily use 50 g of supplements per day or more, a reporting threshold value of 10 ng/g or 10 ppb for all anabolic steroids is used in all tests. This value also allows for individual variations in metabolism. Excretion studies for stimulants are rare, but similar considerations led to the conclusion that for stimulants, a reporting threshold value of 100 ppb is opportune.
Since Mr. Contador has denied using any supplements during the time period in which he tested positive for clenbuterol, we can’t ask the pertinent question: how much supplement did he consume? But if we use the 50 g amount suggested by de Hon and Coumans, and the 100 ng/g standard, we can calculate that an athlete could ingest as much as 5 ug of clenbuterol from consumption of a supplement approved for use by NZVT. This is five times the likely maximum level of clenbuterol present in Mr. Contador’s system.
Thus we can conclude with a very high degree of probability that if Mr. Contador’s clenbuterol positive did in fact result from a contaminated supplement, this supplement would have met the standard for contaminant-free of NZVT, a standard used by other organizations as well. How can an athlete possibly be sanctioned for using a supplement approved by a national federation, on the basis of a widely used industry standard?
I don’t know whether or not cognizance of this point would affect your conclusion in this specific case or not. But at the very least, I think CAS is remiss in not pointing out the implications of its decision: that athletes can be sanctioned for consuming supplements that are approved by national anti-doping organizations. Several athletes have tested positive for levels of clenbuterol in urine substantially lower than Mr. Contador’s, and though they were not sanctioned, this was because they were able to make the case that the clenbuterol derived from contaminated meat in the country where they were competing at the time. Had they tested at such levels in Europe, however, this rationale probably would not have been accepted, and they very likely would have faced sanctions.
In addition to this problem, CAS has to my eyes also seriously misreported a value in its award. In article 16, and again in article 416, it’s stated that a blood test for clenbuterol in Mr. Contador determined a value of 1 ug/ml. This value cannot possibly be correct. Assuming a total blood volume of approximately 7 liters, it would indicate a consumption of at least 7 mg of clenbuterol. No one could take a dose remotely close to this and not experience very severe adverse symptoms, if not death itself. A level of 1 ug/ml is also grotesquely inconsistent with the reported urine values of Mr. Contador in the low pg/ml range, all four of which are reasonably consistent with each other and suggest, as I noted earlier, an ingestion of roughly 500 ng.
CAS has already acknowledged an inconsistency in its report regarding the date of this blood test. I hope it will now issue a clarification regarding this value, as well as acknowledge that there is a very serious problem when an athlete can be sanctioned for taking a supplement that is determined to be clean by a national antidoping organization.
Sincerely yours,
